By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS


Industry
Biotechnology






Company News
Amarantus BioSciences, Inc. , US Army, And Rutgers University In Partnership To Expand Development Of Engineered Skin Substitute (ESS) For The Treatment Of Severe Thermal Burn Wounds 8/3/2015 7:15:59 AM
Amarantus BioSciences, Inc. Announces First Patient Dosed In Eltoprazine Phase IIb Study For Treatment Of Parkinson's Disease Levodopa-Induced Dyskinesia 7/20/2015 7:17:44 AM
Amarantus BioSciences, Inc. Completes Acquisition Of ESS From Lonza Group Ltd. (LZAGY.PK) For The Treatment Of Severe Burns 7/15/2015 7:14:21 AM
Amarantus BioSciences, Inc. To Commence Trading On The OTCQX Marketplace Under Existing Ticker Symbol AMBS 7/13/2015 7:10:47 AM
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent No. 9,066,903 Covering Proprietary Methods Of Administration Of Eltoprazine For The Treatment Of Parkinson's Disease 6/30/2015 7:24:45 AM
Amarantus BioSciences, Inc. To Present At The BIO International Convention 6/10/2015 8:00:48 AM
Amarantus BioSciences, Inc. Completes Capital Restructuring In Preparation For National Exchange Listing 6/10/2015 7:27:02 AM
Amarantus BioSciences, Inc. Opens First Clinical Trial Site And Commences Patient Enrollment For Lead Product Candidate Eltoprazine's Phase IIb Study In Parkinson's Disease Levodopa-Induced Dyskinesia 6/5/2015 7:17:34 AM
Amarantus BioSciences, Inc. To Present At The Fourth Annual SeeThru Equity Microcap Investor Conference On May 28, 2015 5/26/2015 7:57:17 AM
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015 6:11:49 AM
12345678910...
//-->